Information:
Error:
ID
20211
Description
This study is a prospective, interventional, open-label, multi-center early access program for the use of Ra-223 Cl2 in HRPC/CRPC (Hormone refractory prostate cancer / Castrate resistant prostate cancer) patients diagnosed with bone metastasis and to collect additional short and long term safety data on the product. NCT01618370
Keywords
Versions (1)
- 2/13/17 2/13/17 -
Uploaded on
February 13, 2017
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Radium-223 Dichloride (Alpharadin) DRKS00006460 NCT01618370 in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases (Prior Therapy)
Radium 223 Dichloride (Alpharadin) - Prior Anti-Cancer Therapy
- StudyEvent: ODM
Similar models
Radium 223 Dichloride (Alpharadin) - Prior Anti-Cancer Therapy
- StudyEvent: ODM
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Prior systemic anti-cancer therapy
Item
Has the subject received any prior systemic anti-cancer therapy?
boolean
C2346834 (UMLS CUI [1,1])
C1514463 (UMLS CUI [1,2])
C1514463 (UMLS CUI [1,2])
Regimen number
Item
Regimen number
text
C0040808 (UMLS CUI [1,1])
C0237753 (UMLS CUI [1,2])
C0237753 (UMLS CUI [1,2])
Intent
Item
Intent
text
C1283828 (UMLS CUI [1,1])
C2346834 (UMLS CUI [1,2])
C2346834 (UMLS CUI [1,2])
Type of treatment
Item
Type
text
C0087111 (UMLS CUI [1])
Drug name
Item
Drug name (Trade Name preferred)
text
C0013227 (UMLS CUI [1])
Start Date
Item
Start Date
date
C0808070 (UMLS CUI [1])
Stop Date
Item
Stop Date
date
C0806020 (UMLS CUI [1])
No comments